“2018-2023 Global & French Pharma Markets” report provides a presentation of the French healthcare system and of the latest measures introduced by health authorities. The report also reviews the current positions of the various stakeholders, evaluates their likely evolutions by 2023 and estimates the impact of these evolutions on the pharma market and on pharma companies strategic priorities
DESCRIPTION
- “2018-2023 Global & French Pharma Markets” report provides a description of the French healthcare system from a legal, organizational and economic point of view
- This edition offers in a clear, precise and concise format:
- A presentation of the French healthcare system and of the latest measures introduced by health authorities
- An analysis of the current positions of stakeholders and of their likely evolutions by 2023
- An assessment of the impact of these evolutions on the pharmaceutical market and on companies by 2023
- Electronic copy: 300 pages (PowerPoint)
- Language: English